Clinical Scorecard: Synergistic Effects of Metformin and Parthenolide on Breast Cancer in Mice Through Induction of Apoptosis and Inhibition of Angiogenesis
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Mice with breast cancer
Care Setting
Key Highlights
Remove 'cure rate of 50%' or rephrase to indicate it is based on study results.
Guideline-Based Recommendations
Diagnosis
Management
Consider combination therapy of metformin and parthenolide for breast cancer treatment based on study findings.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Breast cancer patients
Combination of metformin and parthenolide may enhance anticancer efficacy.
